| P50 | author | Tiandao Li | Q55283595 |
| | David H. Gutmann | Q56670301 |
| P2093 | author name string | Robert S Fulton | |
| | Christopher A Miller | |
| | Katherine DeSchryver | |
| | Sandra McDonald | |
| | Timothy J Ley | |
| | Melike Pekmezci | |
| | Arie Perry | |
| | Eric J Duncavage | |
| | Haley J Abel | |
| | Sonika Dahiya | |
| | Xiaochun Zhang | |
| | Angela C Hirbe | |
| | Karlyne M Reilly | |
| | Jessica Walrath | |
| P2860 | cites work | A widely expressed betaIII spectrin associated with Golgi and cytoplasmic vesicles | Q22008043 |
| | Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin | Q24323104 |
| | VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing | Q24628978 |
| | Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow | Q24645717 |
| | Fast and accurate short read alignment with Burrows-Wheeler transform | Q24653853 |
| | Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR | Q24795409 |
| | The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data | Q27860742 |
| | The Sequence Alignment/Map format and SAMtools | Q27860966 |
| | The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 |
| | Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation | Q28266922 |
| | Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 |
| | CXCR4 regulates growth of both primary and metastatic breast cancer | Q28296113 |
| | Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours | Q28306740 |
| | Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation | Q28507521 |
| | Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects | Q28511432 |
| | Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors. | Q53402903 |
| | High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization. | Q53549151 |
| | Array-Based Comparative Genomic Hybridization Identifies CDK4 and FOXM1 Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor | Q61829389 |
| | Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms | Q61829515 |
| | National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987 | Q67261485 |
| | TP53 mutations are frequent in malignant NF1 tumors | Q71648002 |
| | Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1 | Q73912508 |
| | p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors | Q79101801 |
| | Germline and somatic NF1 gene mutations in plexiform neurofibromas | Q81290217 |
| | Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings | Q83189354 |
| | Mouse models of tumor development in neurofibromatosis type 1 | Q28591083 |
| | Mouse tumor model for neurofibromatosis type 1 | Q28591456 |
| | Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads | Q29617402 |
| | Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells | Q33757962 |
| | Loss of beta-III spectrin leads to Purkinje cell dysfunction recapitulating the behavior and neuropathology of spinocerebellar ataxia type 5 in humans. | Q33801655 |
| | Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis | Q33826589 |
| | Mutant β-III spectrin causes mGluR1α mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5. | Q33935986 |
| | CD44 and p53 immunoexpression patterns in NF1 neoplasms - indicators of malignancy and infiltration. | Q33962059 |
| | SomaticSniper: identification of somatic point mutations in whole genome sequencing data | Q34095911 |
| | TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions | Q34105259 |
| | Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs | Q34274529 |
| | Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues | Q34498687 |
| | Neurofibromas in NF1: Schwann cell origin and role of tumor environment | Q34509108 |
| | Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). | Q35058504 |
| | Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis | Q35558868 |
| | Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system | Q35686940 |
| | Recent advances in neurofibromatosis type 1. | Q35691343 |
| | Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent manner. | Q35711858 |
| | NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors | Q35746617 |
| | Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation | Q35788039 |
| | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene | Q36042066 |
| | βIII spectrin regulates the structural integrity and the secretory protein transport of the Golgi complex | Q36561930 |
| | Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 | Q36653938 |
| | KRAB-Zinc Finger Proteins: A Repressor Family Displaying Multiple Biological Functions. | Q37065382 |
| | Spectrin: structure, function and disease | Q38168494 |
| | Survivin beyond physiology: orchestration of multistep carcinogenesis and therapeutic potentials | Q38190309 |
| | Neurofibromatosis type 1: a multidisciplinary approach to care | Q38230259 |
| | Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis | Q38327730 |
| | Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms | Q39030536 |
| | Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1. | Q39857065 |
| | Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors. | Q40480120 |
| | Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors | Q40543125 |
| | Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor. | Q40774788 |
| | BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. | Q42533125 |
| | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1 | Q42729073 |
| | Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors | Q44943632 |
| | Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome | Q47322886 |
| | Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours | Q48524485 |
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mutation | Q42918 |
| P304 | page(s) | 4201-4211 | |
| P577 | publication date | 2015-04-29 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma | |
| P478 | volume | 21 | |